BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sartim AG, Marques J, Silveira KM, Gobira PH, Guimarães FS, Wegener G, Joca SR. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects. Neuropharmacology 2021;195:108679. [PMID: 34157363 DOI: 10.1016/j.neuropharm.2021.108679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Gobira PH, LaMar J, Marques J, Sartim A, Silveira K, Santos L, Wegener G, Guimaraes FS, Mackie K, Lu HC, Joca S. CB1 Receptor Silencing Attenuates Ketamine-Induced Hyperlocomotion Without Compromising Its Antidepressant-Like Effects. Cannabis Cannabinoid Res 2022. [PMID: 36067014 DOI: 10.1089/can.2022.0072] [Reference Citation Analysis]
2 Sharafi A, Pakkhesal S, Fakhari A, Khajehnasiri N, Ahmadalipour A. Rapid treatments for depression: Endocannabinoid system as a therapeutic target. Neurosci Biobehav Rev 2022;137:104635. [PMID: 35351488 DOI: 10.1016/j.neubiorev.2022.104635] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Calapai F, Cardia L, Calapai G, Di Mauro D, Trimarchi F, Ammendolia I, Mannucci C. Effects of Cannabidiol on Locomotor Activity. Life 2022;12:652. [DOI: 10.3390/life12050652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Poulia N, Delis F, Brakatselos C, Ntoulas G, Asprogerakas MZ, Antoniou K. CBD Effects on Motor Profile and Neurobiological Indices Related to Glutamatergic Function Induced by Repeated Ketamine Pre-Administration. Front Pharmacol 2021;12:746935. [PMID: 34776964 DOI: 10.3389/fphar.2021.746935] [Reference Citation Analysis]